Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Tumor characteristics and prognosis in familial breast cancer.

Arpino G, Pensabene M, Condello C, Ruocco R, Cerillo I, Lauria R, Forestieri V, Giuliano M, De Angelis C, Montella M, Crispo A, De Placido S.

BMC Cancer. 2016 Nov 29;16(1):924.

2.

Psychosocial Adjustment and Perceived Risk Among Adolescent Girls From Families With BRCA1/2 or Breast Cancer History.

Bradbury AR, Patrick-Miller L, Schwartz LA, Egleston BL, Henry-Moss D, Domchek SM, Daly MB, Tuchman L, Moore C, Rauch PK, Shorter R, Karpink K, Sands CB.

J Clin Oncol. 2016 Oct 1;34(28):3409-16. doi: 10.1200/JCO.2015.66.3450. Epub 2016 Aug 22.

PMID:
27551110
3.

A review of consent practices and perspectives for pharmacogenetic testing.

Haga SB, Mills R.

Pharmacogenomics. 2016 Sep;17(14):1595-605. doi: 10.2217/pgs-2016-0039. Epub 2016 Aug 17.

PMID:
27533720
4.

The Brazilian Hereditary Cancer Network: historical aspects and challenges for clinical cancer genetics in the public health care system in Brazil.

Ashton-Prolla P, Seuanez HN.

Genet Mol Biol. 2016 Jun 3;39(2):163-5. doi: 10.1590/1678-4685-GMB-2014-0373. No abstract available.

5.

Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.

Buchanan AH, Voils CI, Schildkraut JM, Fine C, Horick NK, Marcom PK, Wiggins K, Skinner CS.

J Genet Couns. 2017 Feb;26(1):79-92. doi: 10.1007/s10897-016-9981-6. Epub 2016 Jun 6.

PMID:
27265406
6.

Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing.

Stanislaw C, Xue Y, Wilcox WR.

Cancer Biol Med. 2016 Mar;13(1):55-67. doi: 10.28092/j.issn.2095-3941.2016.0002.

7.

Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study.

Daly MB, Montgomery S, Bingler R, Ruth K.

Fam Cancer. 2016 Oct;15(4):697-706. doi: 10.1007/s10689-016-9889-1.

8.

Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.

Parsons DW, Roy A, Yang Y, Wang T, Scollon S, Bergstrom K, Kerstein RA, Gutierrez S, Petersen AK, Bavle A, Lin FY, López-Terrada DH, Monzon FA, Hicks MJ, Eldin KW, Quintanilla NM, Adesina AM, Mohila CA, Whitehead W, Jea A, Vasudevan SA, Nuchtern JG, Ramamurthy U, McGuire AL, Hilsenbeck SG, Reid JG, Muzny DM, Wheeler DA, Berg SL, Chintagumpala MM, Eng CM, Gibbs RA, Plon SE.

JAMA Oncol. 2016 Jan 28. doi: 10.1001/jamaoncol.2015.5699. [Epub ahead of print]

PMID:
26822237
9.

Hereditary Factors in Esophageal Adenocarcinoma.

van Nistelrooij AM, Dinjens WN, Wagner A, Spaander MC, van Lanschot JJ, Wijnhoven BP.

Gastrointest Tumors. 2014 Jun;1(2):93-8. doi: 10.1159/000362575. Epub 2014 May 9. Review.

10.

A vicious cycle of acute catecholamine cardiomyopathy and circulatory collapse secondary to pheochromocytoma.

Otusanya O, Goraya H, Iyer P, Landi K, Tibb A, Msaouel P.

Oxf Med Case Reports. 2015 Oct 27;2015(10):343-5. doi: 10.1093/omcr/omv058. eCollection 2015 Oct.

11.

Clinical Characteristics of Multiple Colorectal Adenoma Patients Without Germline APC or MYH Mutations.

Tieu AH, Edelstein D, Axilbund J, Romans KE, Brosens LA, Wiley E, Hylind L, Giardiello FM.

J Clin Gastroenterol. 2016 Aug;50(7):584-8. doi: 10.1097/MCG.0000000000000416.

PMID:
26485104
12.

Psychosocial Adjustment in School-age Girls With a Family History of Breast Cancer.

Bradbury AR, Patrick-Miller L, Schwartz L, Egleston B, Sands CB, Chung WK, Glendon G, McDonald JA, Moore C, Rauch P, Tuchman L, Andrulis IL, Buys SS, Frost CJ, Keegan TH, Knight JA, Terry MB, John EM, Daly MB.

Pediatrics. 2015 Nov;136(5):927-37. doi: 10.1542/peds.2015-0498. Epub 2015 Oct 19.

13.

Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations.

Wolf SM, Branum R, Koenig BA, Petersen GM, Berry SA, Beskow LM, Daly MB, Fernandez CV, Green RC, LeRoy BS, Lindor NM, O'Rourke PP, Breitkopf CR, Rothstein MA, Van Ness B, Wilfond BS.

J Law Med Ethics. 2015 Fall;43(3):440-63. doi: 10.1111/jlme.12288.

14.

A Novel WRN Frameshift Mutation Identified by Multiplex Genetic Testing in a Family with Multiple Cases of Cancer.

Yang L, Wang G, Zhao X, Ye S, Shen P, Wang W, Zheng S.

PLoS One. 2015 Aug 4;10(8):e0133020. doi: 10.1371/journal.pone.0133020. eCollection 2015.

15.

Getting personal: Head and neck cancer management in the era of genomic medicine.

Birkeland AC, Uhlmann WR, Brenner JC, Shuman AG.

Head Neck. 2016 Apr;38 Suppl 1:E2250-8. doi: 10.1002/hed.24132. Epub 2015 Aug 13. Review.

16.

Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.

Buchanan AH, Datta SK, Skinner CS, Hollowell GP, Beresford HF, Freeland T, Rogers B, Boling J, Marcom PK, Adams MB.

J Genet Couns. 2015 Dec;24(6):961-70. doi: 10.1007/s10897-015-9836-6. Epub 2015 Apr 3.

17.

Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample.

Knight SJ, Mohamed AF, Marshall DA, Ladabaum U, Phillips KA, Walsh JM.

Med Decis Making. 2015 Jan 14. pii: 0272989X14565820. [Epub ahead of print]

18.

Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening.

Kilambi V, Johnson FR, González JM, Mohamed AF.

Value Health. 2014 Dec;17(8):838-45. doi: 10.1016/j.jval.2014.09.001. Epub 2014 Nov 6.

19.

Breast cancer genetic testing awareness, attitudes and intentions of Latinas living along the US-Mexico border: a qualitative study.

Chalela P, Pagán JA, Su D, Muñoz E, Ramirez AG.

J Community Med Health Educ. 2012;2. pii: 1000152.

20.

Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition.

Patrick-Miller LJ, Egleston BL, Fetzer D, Forman A, Bealin L, Rybak C, Peterson C, Corbman M, Albarracin J, Stevens E, Daly MB, Bradbury AR.

JMIR Res Protoc. 2014 Oct 29;3(4):e49. doi: 10.2196/resprot.3337.

Supplemental Content

Support Center